article thumbnail

Guest Post: Sony fails in strike out claim against Hendrix bandmates

The IPKat

This is an interesting legal question as the Copyright, Designs and Patents Act 1988 (the CDPA) brought in new performers’ rights, even for earlier performances such as Mitchell’s and Redding’s subject to transitional provisions regarding prior contracts. The wider context of this case is an industry where “catalogue” (i.e.

Copyright 107
article thumbnail

Connecticut’s Privacy Law Signed by Governor

LexBlog IP

It: sets responsibilities and privacy protection standards for data controllers; gives consumers the right to access, correct, delete, and obtain a copy of personal data and to opt out of the processing or personal data for certain purposes (e.g., The CPDPA is designed to establish a framework for controlling and processing personal data.

Privacy 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Supporting MSME

Biswajit Sarkar Copyright Blog

As India aims for a $5 trillion economy, the MSME ministry sets ambitious goals, aiming to elevate their GDP contribution by up to 50% by 2025. They make a significant contribution, accounting for over 29% of the GDP and powering half of the country’s total exports.

article thumbnail

Privacy and Security Roundup: New consumer privacy laws, big developments in ransomware attacks and the FBI’s Operation Trojan Shield

LexBlog IP

.’s GDPR including a requirement for “controllers” to conduct data protection assessments for certain processing activities and requires controllers and “processors” enter into contracts that provide specific instructions concerning how person data is processed. Obtain a portable copy of the data.

Privacy 52
article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

In particular, under the new amendments, reference product sponsors (RPSs) are required to provide FDA with copies of any patent lists, along with patent expiration dates, within 30 days of when they were first provided to biosimilar applicants as part of the patent dance (pursuant to 42 U.S.C. § 262( l )(3)(A) or ( l )(7)).